RxDoctor Payments Data

Marcelle Saurman, NP

Adult Health · Chelmsford, MANPI 1003353012

Payments from drug & device makers

$898in general payments, 2019–2025

Across 35 payments — averaging $25.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$270
  • Astellas Pharma US Inc$150
  • Ferring Pharmaceuticals Inc.$97
  • Johnson & Johnson$80
  • Laborie Medical Technologies Corp.$65
  • Boston Scientific$58
  • plus $176 from 8 others

What the payments were for

  • Food & beverage$82292%
  • Education$768%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$898 in reported general payments places this provider in the 75th percentile of 671 adult health providers in Massachusetts.

See all adult health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$84,477
Medicare patients
415
Services billed
1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron78$50,704
GemtesaVibegron72$41,580
Tamsulosin Hcl477$10,913
Mirabegron ErMirabegron16$7,987
Methenamine Hippurate71$3,832
Finasteride217$3,604
Trospium Chloride31$2,953
Trospium Chloride ErTrospium Chloride15$2,414
Cefpodoxime Proxetil20$1,747
Estradiol38$1,705
Darifenacin ErDarifenacin Hydrobromide19$1,536
Tadalafil18$921
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$423
Oxybutynin Chloride ErOxybutynin Chloride16$380
Alfuzosin Hcl ErAlfuzosin Hcl19$364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$150$50,70478 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 671 adult health providers in Massachusetts.

Other adult health in Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →